The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ka wei di luo dui xin li shuai jie huan zhe xin gong neng de ying xiang
Author(s): 
Pages: 38-39
Year: Issue:  1
Journal: JIANGSU PHARMACEUTICAL AND CLINICAL RESEARCH

Keyword:  卡维地洛心力衰竭;
Abstract: 目的考察第三代β-受体阻滞剂卡维地洛(金洛片)对心力衰竭的临床疗效.方法患者56例,其中男性30例,女性26例,年龄28~72岁.心功能(NYHA)Ⅱ级20例,Ⅲ级32例,Ⅳ级4例.入选病人分为2组:对照组、实验组.对照组在常规治疗使用强心等抗心衰药物的基础上加服安慰剂;实验组在常规治疗使用强心等抗心衰药物的基础上加服卡维地洛;治疗3个月观察其疗效.结果实验组显效63.3%,有效30%,总有效率93.3%.结论实验组明显高于对照组,卡维地洛是治疗心衰安全有效的药物.
Related Articles
No related articles found